03:36 PM EDT, 06/06/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.4%.
The iShares Biotechnology ETF (IBB) eased 0.2%.
In corporate news, Replimune ( REPL ) shares surged 25% after follow-up analysis from a trial showed a third of anti-PD1 failed melanoma patients receiving the company's RP1 plus nivolumab responded to treatment.